- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -
Avastin Compares to Lucentis
Posted By Dr. Randall Wong On February 18, 2010 @ 6:26 pm In Retina | Comments Disabled
Finally a small study is confirming what many of us have been suspecting; Avastin, for the treatment of wet macular degeneration, is clinically comparable to Lucentis.
In a retrospective study, over 450 patient charts were reviewed. All were treated with either bevacizumab (Avastin) or ranibizumab (Lucentis). The authors found that the clinical outcomes were similar as were adverse events. Patients receiving bevacizumab required fewer injections over the course of a year.
What Dose This Mean? Cost seems, now, to be the only barrier for use. Avastin is much cheaper than Lucentis. This is the first study that indicates clinical similarity; a more formal prospective trial comparing the two drugs head to head will complete in 2011. It does; however, validate the off-label use of Avastin by retina specialists.
Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com
URL to article: http://eyedocnews.com/002868-avastin-compares-to-lucentis/
URLs in this post:
[1] Randall V. Wong, M.D.: http://RetinaEyeDoctor.com/About
Click here to print.
Copyright © 2008 Eye Doc Talk. All rights reserved.